This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignees: Assistance Publique-Hopitaux De Paris, National Institute of Health and Medical Research, Universitè De Montpellier. Active years: 2016-2026.
Company Filing History:
2 out of 331 
2 out of 1,853 
2 out of 297 
Years Active: 2016-2026
Title: The Innovative Contributions of Olivier Cazorla in Cardiac Research
Introduction
Olivier Cazorla, a prominent inventor based in Montpellier, France, has made significant strides in the field of cardiac research. With a focus on innovative methods to treat myocardial infarction, he holds two patents that showcase his dedication to advancing medical science.
Latest Patents
Cazorla's latest patents revolve around groundbreaking methods for treating myocardial infarction through the administration of sonic hedgehog. These inventions pertain to pharmaceutical compositions and methods aimed at providing cardioprotection for individuals who have experienced a myocardial infarction. The patents detail the use of a ligand of the sonic hedgehog signaling pathway, demonstrating Cazorla's commitment to enhancing recovery options for cardiac patients.
Career Highlights
Throughout his career, Olivier Cazorla has been associated with prestigious institutions such as the Institut National de la Santé et de la Recherche Médicale and the Université de Montpellier. His work at these organizations has allowed him to push the boundaries of cardiac research, aligning his inventions with the urgent need for improved treatments in the medical field.
Collaborations
Cazorla has collaborated with esteemed professionals in the field, including Alain Lacampagne and Jerome Thireau. These collaborations have fostered an environment of innovation and shared expertise, contributing to the effective development of his patents and strengthening the relevance of his research in the medical community.
Conclusion
Olivier Cazorla stands out as an influential inventor in the realm of cardiac treatments. His patents not only reflect his inventive spirit but also highlight the potential impact on patient care for those suffering from myocardial infarctions. Through his collaborations and work with reputable institutions, Cazorla continues to pave the way for future innovations in medical science.